SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. It operates through SQZ cell therapy platform, which uses membrane disruption to deliver material into cells. The company was founded by Robert S. Langer Jr., Klavis F. Jensen, Agustin Lopez Marquez, and Armon Sharei in March 2013 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. SQZ Biotechnologies Co market cap is $707,787.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. SQZ Biotechnologies Co 52 week high is $0.05 as of November 20, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. SQZ Biotechnologies Co 52 week low is $0.01 as of November 20, 2026.
SQZ Biotechnologies Co stock price today is $0.024.
SQZ Biotechnologies Co stock price yesterday was $0.024.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. SQZ Biotechnologies Co 50-day moving average is $0.024.